PAPER Marco JL, de los Ríos C, Carreiras MC, Baños JE, Badía A, Vivas NM
SEARCH RESULTS
331397 RESULTS
PAPER Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, Rossor AM, Stevens JM, Cipolotti L, Rossor MN
Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease.
Ann Neurol. 2001 Apr;49(4):433-42. PubMed: 11310620PAPER Matsui T, Morikawa Y, Tojo M, Okamura N, Maruyama M, Hirai H, Chiba H, Matsushita S, Higuchi S, Arai H, Sasaki H
Cathepsin D polymorphism not associated with Alzheimer's disease in Japanese.
Ann Neurol. 2001 Apr;49(4):544-5. PubMed: 11310638PAPER Hampel H, Buerger K, Kohnken R, Teipel SJ, Zinkowski R, Moeller HJ, Rapoport SI, Davies P
Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231.
Ann Neurol. 2001 Apr;49(4):545-6. PubMed: 11310639PAPER Norton LE, Ostergaard AL
Priming performance in Alzheimer's disease: the role of task sensitivity.
J Int Neuropsychol Soc. 2001 Mar;7(3):294-301. PubMed: 11311030PAPER Fama R, Shear PK, Marsh L, Yesavage JA, Tinklenberg JR, Lim KO, Pfefferbaum A, Sullivan EV
Remote memory for public figures in Alzheimer's disease: relationships to regional cortical and limbic brain volumes.
J Int Neuropsychol Soc. 2001 Mar;7(3):384-90. PubMed: 11311039PAPER Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X, Proud CG
The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.
Biochem J. 2001 May 1;355(Pt 3):609-15. PubMed: 11311121PAPER Walsh DM, Hartley DM, Condron MM, Selkoe DJ, Teplow DB
In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692--> Gly) Alzheimer's disease.
Biochem J. 2001 May 1;355(Pt 3):869-77. PubMed: 11311152PAPER Iseki E, Kato M, Marui W, Uéda K, Kosaka K
A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies.
J Neurol Sci. 2001 Apr 1;185(2):129-34. PubMed: 11311294PAPER Blasko I, Ransmayr G, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B
Does IFNgamma play a role in neurodegeneration?
J Neuroimmunol. 2001 May 1;116(1):1-4. PubMed: 11311323PAPER Rakonczay Z, Papp H
Effects of chronic metrifonate treatment on cholinergic enzymes and the blood-brain barrier.
Neurochem Int. 2001 Jul;39(1):19-24. PubMed: 11311445PAPER Farkas E, Luiten PG
Cerebral microvascular pathology in aging and Alzheimer's disease.
Prog Neurobiol. 2001 Aug;64(6):575-611. PubMed: 11311463PAPER Engidawork E, Gulesserian T, Seidl R, Cairns N, Lubec G
Expression of apoptosis related proteins in brains of patients with Alzheimer's disease.
Neurosci Lett. 2001 May 4;303(2):79-82. PubMed: 11311497PAPER Masullo C, Daniele A, Fazio VM, Seripa D, Gravina C, Filippini V, Grossi D, Fragassi N, Nichelli P, Leone M, Gainotti G
The Apolipoprotein E genotype in patients affected by syndromes with focal cortical atrophy.
Neurosci Lett. 2001 May 4;303(2):87-90. PubMed: 11311499PAPER Petegnief V, Saura J, de Gregorio-Rocasolano N, Paul SM
Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E.
Neuroscience. 2001;104(1):223-34. PubMed: 11311545Current Filters
No filters selected